She is a neurogeneticist with a focus on the complex genetics of Alzheimer’s disease, other neurodegenerative diseases, and quantitative endophenotypes. She is also a practicing board-certified neurologist with subspecialty training in behavioral neurology. The Ertekin-Taner Laboratory has continually been funded by the NIH and Foundation grants focused on the discovery and characterization of genetic risk factors in Alzheimer’s disease and progressive supranuclear palsy. Her current research aims to discover the precise transcriptional regulatory changes that underlie risk for neurodegenerative diseases, their functional outcomes, and risk-variant discovery in ethnic minorities and atypical forms of Alzheimer’s disease.